Lack of research into whether monkeypox infections have long-term consequences
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
...
The trial will evaluate the drug’s safety and its ability to mitigate monkeypox symptoms and prevent serious outcomes, including death.
...
Submitted by mike kraft on
ALSO SEE: Outbreak Brief 11: Monkeypox in Africa Union Member States
Submitted by mike kraft on
The trial could get underway within a couple of weeks and definitely before the end of October, said Ana Maria Henao-Restrepo, who heads WHO’s R&D Blueprint effort to develop drugs, diagnostics, and vaccines to respond to outbreaks of rare and dangerous pathogens.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on